Worldwide: Compliance

As Washington prepares for midterm elections, federal contractors face a potentially transformed oversight landscape. A shift in congressional control could trigger aggressive investigations into procurement integrity, conflicts of interest, and contractor relationships, with ongoing inspector general audits already providing a roadmap for future congressional scrutiny.

Eli Lilly has implemented an expanded claims-data policy that ties access to 340B drug pricing to covered entities' submission of pharmacy and medical claims data.

Manufacturing supply chains face escalating cyber threats as digital transformation accelerates across the sector.

The Office of Management and Budget has proposed sweeping changes to federal financial assistance regulations that would centralize authority and potentially override agency-specific rules across government programs.

Commissioner Hester Peirce's farewell speech articulates a defining principle of her SEC tenure: the Commission's regulatory authority must remain bounded by statutory and constitutional limits.

17 CFR Part 209 prescribes forms under the SEC's Rules of Practice, with Form D-A serving as the primary mechanism for disclosure of assets and financial information in enforcement matters.

The DEA's 2026 marijuana rescheduling hearing has excluded all proponents of Schedule III classification, allowing only prohibitionist voices to participate.

New York Commercial Division judges are integrating generative AI into litigation practices to boost efficiency, but they're also grappling with significant challenges including accuracy concerns, potential bias, and confidentiality risks. Courts are establishing new standards for disclosure, verification, and attorney accountability as AI becomes an increasingly common tool in legal proceedings.

The U.S. Department of Transportation has issued critical guidance clarifying that positive marijuana test results for safety-sensitive employees cannot be verified as negative based on state-legal medical marijuana use, even after federal rescheduling.